by Paulick Report Staff Dr. Mary Scollay, Dr. Rick Arthur, and Dr. Lynn Hovda submitted the following letter to the Paulick Report voicing their support of the RCI’s recent decision to establish rules on compounded medications in horse racing: The Association of Racing Commissioners International (RCI) recently announced they have given approval to a Model
By Blood-Horse Staff The Association of Racing Commissioners International said Jan. 5 it is taking steps to ensure regulatory agencies have adequate authority to sanction licensees who violate existing federal restrictions limiting the use of illegally compounded medications. An already approved model rules policy would outlaw the possession or use of a drug, substance, or
NEWS RELEASE July 2, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC ISSUES DRUG BULLETINS ON PURPLE PAIN AND TB-500 The Racing Medication and Testing Consortium (RMTC) Tactical Research Committee has reviewed data from laboratory analysis of two substances of concern in racing that have been marketed as powerfully effective drugs – “Purple Pain” and
NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing Consortium (RMTC) board of directors adopted recommendations for thresholds and withdrawal times for four therapeutic medications identified by the Association
NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC) board of directors addressed a number of important initiatives including therapeutic medications, laboratory proficiency, corticosteroid regulation and penalties for rule
NEWS RELEASE April 20, 2011 Contact: Hallie Lewis (859) 224-2848 RMTC JOINS NTRA AND AAEP IN ORGANIZING UPCOMING INTERNATIONAL SUMMIT TO ADDRESS RACE DAY MEDICATION The Racing Medication and Testing Consortium (RMTC) board of directors announced today that it will join the National Thoroughbred Racing Association (NTRA) and American Association of Equine Practitioners (AAEP) in
NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has recommended scientifically identified withdrawal guidelines and plasma thresholds for the
NEWS RELEASE June 11, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC EAGERLY ANTICIPATES NSAID DISCUSSION WHEN RCI MODEL RULES COMMITTEE CONVENES IN JULY A recently published report previewing the National Horsemen’s Benevolent and Protective Association (HBPA) Summer Convention in Minneapolis in late July seemed to indicate that there was little support for proposed changes in
NEWS RELEASE April 15, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC RECOMMENDS NEW PHENYLBUTAZONE THRESHOLD LEVEL, ANNOUNCES LAUNCH OF RECENT RULINGS DATABASE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has revised its recommended threshold for the non-steroidal anti-inflammatory drug (NSAID) phenylbutazone from 5
NEWS RELEASE October 1, 2009 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD FORMS COMMITTEE TO OVERSEE IMPLEMENTATION OF DTI TASK FORCE RECOMMENDATIONS Moving forward with its initiative to significantly change the structure of drug testing in U.S. horse racing, the Racing Medication and Testing Consortium (RMTC) board of directors has approved the formation of a
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
